ATC Group: L02AE04 Triptorelin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L02AE04 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L02 Endocrine therapy
3 L02A Hormones and related agents
4 L02AE Gonadotropin releasing hormone analogues
5 L02AE04 Triptorelin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 0.1 mg
PAREN - Parenteral (depot) 134 mg

Active ingredients in L02AE04

Active Ingredient Description
Triptorelin

Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.

Related product monographs

Title Information Source Document Type  
DECAPEPTYL SR Powder and solvent for suspension for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DECAPEPTYL SR Powder for suspension for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DIPHERELINE Powder and solvent for suspension for injection Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC
GONAPEPTYL DEPOT Powder and solvent for suspension for injection prolonged release Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SALVACYL Powder and solvent for prolonged-release suspension for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TRELSTAR Suspension for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Australia (AU)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Romania (RO)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.